U.S. Food and Drug Administration's (FDA) approval last week facilitates nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass.
The FDA granted 510(k) clearance for marketing and use of a combination of blood tests for proteins HE4 and CA125 with the Risk of Ovarian Malignancy Algorithm (ROMA). Research demonstrates that examining levels of HE4 and CA125 using the ROMA algorithm shows the highest accuracy in determining www.medindia.net
...Read On
The targeted drug Xalkori™ (crizotinib) has been approved by the US Food and Drug Administration for the treatment of advanced non-small lung cancer that has an abnormal version of the ALK gene.
Lung cancer is the leading cause of cancer death in the US and around the world, highlighting the importance of developing effective new approaches news.cancerconnect.com
Approval last week by U.S. Food and Drug Administration (FDA) clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass. The FDA granted 510(k) clearance for marketing and use of a combination of blood tests for proteins HE4 and CA125 with the Risk of Ovarian Malignancy Algorithm (ROMA™) www.medicalnewstoday.com
...Read On
Recent approval by the US Food and Drug Administration clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass. www.sciencedaily.com
...Read On
Ali Gorman, R.N. More: Bio, Facebook, Twitter, News Team August 30, 2011 (WPVI) -- The Food and Drug Administration recently approved two new drugs that could be revolutionary. They will dramatically raise the cure rate for a disease that ot too long ago didn't have a treatment.
When Kelly Ann Hester learned she had Hepatitis C in 1993, the disease didn't even have a formal name and doctors didn't give the young mother much of a futureContinue reading..
You can link to this article on your web site using following code:
Website Code:
Forum Code:
Comments
We're looking for comments that are interesting, substantial or highly amusing. If your comments are excessively self-promotional (use your real name, no keywords please), obnoxious, or even worse, boring, you will be banned from commenting. Your comment must be related to the post. Please do not comment on how great or wonderful the post is. All comments are moderated and, if approved, will display in less than 24 hours.
